| Primary information |
|---|
| OV_ID | OV_856 |
| Virus Name | Adenovirus |
| Strain | CV890 |
| Virus type | DNA |
| Virus family | Adenoviridae |
| Modification in virus genome | E1A and E1B gene under control of Adenovirus promoter |
| Virus alone | No |
| Virus in combination iwth drug/radiation | Virus strain in combination with Doxorubicin (10ng/ml) |
| Immune gene induction in virus genome | No |
| Source of cell line | ATCC |
| Origin of cell line | Human hepatoma cell line |
| Cell line | Hep3B |
| Concentration of cell line | 0 |
| In-vitro toxicity | NA |
| Assay | MTT assay |
| In-vitro virus concentration | 0.01pfu/cell |
| In-vitro result | 90% cancer cell killing after day 9, showing synergism with drug |
| Model organism | No |
| In-vivo virus concentration | No |
| In-vivo toxicity | NA |
| In-vivo result | No response |
| Mode of delivery | NA |
| Pathway induction | NA |
| Immunogenic effect | NA |
| Clinical trial | NA |
| PMID | 11522637 |